The ability to meet the challenges faced in medicine every day rises from the development and transformation of technology into ever more effective instruments.
Our hopes are focused on the human dedication and knowledge for a healthy lifestyle, we support progress in the medical field through innovation.

What I’m hoping for is a paradigm shift that sees diagnostics and surgery ever more united in the operating theatre.

Prof. Heber VerriManaging Director, Imagensys

Technological innovation is key to the development of nuclear medicine. Team work is essential to pursue and reach its goals.

Prof. Marco SalvatoreSDN Foundation for Research and Higher Education in Nuclear Diagnostics

Research at the service of technological development is revolutionising diagnostic and surgical techniques.

Prof. Alessandro SoluriCNR, Italian National Research Council
Uncategorized

AIIC Healthcare Innovation Special Prize

The start-up Imagensys is award winner at the Naples PNI Imagensys has won the AIIC…
Uncategorized

Imagensys wins the 2018 AIIC Health Technology Challenge award

Imagensys, a start-up founded in 2017 by CNR researchers, has won the 2018 Health Technology…
Uncategorized

Imagensys wins the 2017 Regione Lazio StartCup

Imagensys, the innovative start-up spun off from CNR researches, has won one of the StartCup…

Pocket Gamma CAM

Pocket GammaCAM raises the bar for detection systems used in nuclear and diagnostic surgery. Its integrated system (detector + monitor) is the most compact in the world, but still offers a much wider field of detection than the existing portable gamma cameras available on the market. It can identify sentinel lymph nodes and lesions of just 2 mm in size.

Pocket GammaCAM acquires images in real time on its monitor and displays a complete scintigraphic image in just 30 seconds.

3D Gamma Probe

D3 Gamma Probe was developed to respond to important challenges in radio-guided surgery: greater speed and greater accuracy in localising lesions and sentinel lymph nodes.

It is the first directional gamma probe to use three simultaneous detectors, capable of offering a greater than 180° field of investigation (against the 60-90° of conventional scintigraphic probes) and guides surgeons on what direction to take the probe in order to reach the lesion quickly.

The evolution of nuclear medicine

Imagensys’ mission is to help medicine respond to the challenges it faces in the fight against cancer.
The constant evolution of instrumentation in the field of diagnostic and surgical imaging technology offers significant scope for development.
Thanks to a long phase of research conducted by CNR, the instruments developed by Imagensys offer radio-guided surgery and diagnostic scintigraphy a step forward in speed, accuracy and efficiency.

Pocket GammaCAM Clinical Trial

Comparative clinical trials for the use of the Pocket GammaCAM in diagnostic imaging are being developed in collaboration with Prof. Marco Salvatore’s team at the SDN Foundation for Research and Higher Education in Nuclear Diagnostics.
Comparative clinical trials for the use of the Pocket GammaCAM in radio-guided surgery are being developed in collaboration with a prestigious Institute of Oncology.

The operative phase of the clinical trials will take place in January-April 2019.

D3 Gamma Probe Clinical Trial

Comparative clinical trials for the use of the D3 Gamma Probe in radio-guided surgery, to demonstrate its quality and strengths, are being developed in collaboration with a prestigious Institute of Oncology.

The operative phase of the clinical trials will take place in January-April 2019